Jiangxi Synergy Pharmaceutical Co., Ltd.

XSEC:300636 Stock Report

Market Cap: CN¥3.5b

Jiangxi Synergy Pharmaceutical Future Growth

Future criteria checks 5/6

Jiangxi Synergy Pharmaceutical is forecast to grow earnings and revenue by 32.9% and 23.1% per annum respectively. EPS is expected to grow by 32.6% per annum. Return on equity is forecast to be 7.8% in 3 years.

Key information

32.9%

Earnings growth rate

32.6%

EPS growth rate

Pharmaceuticals earnings growth18.7%
Revenue growth rate23.1%
Future return on equity7.8%
Analyst coverage

Low

Last updated25 Oct 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSEC:300636 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,233263N/A2722
12/31/2025999195N/A2142
12/31/2024806147N/A2742
9/30/202473212399220N/A
6/30/2024722119-14124N/A
3/31/2024708116-40108N/A
12/31/2023722106-51164N/A
9/30/2023751105-70160N/A
6/30/2023766115-51211N/A
3/31/2023761107-114185N/A
1/1/2023720101-115196N/A
9/30/202269289-171172N/A
6/30/202265181-189193N/A
3/31/202263588-219206N/A
12/31/202159281-293131N/A
9/30/202152476-312109N/A
6/30/202147671-29073N/A
3/31/202147674-22689N/A
12/31/202043570-15080N/A
9/30/202047167-12454N/A
6/30/202045563-12823N/A
3/31/202042860-1394N/A
12/31/201941348-213-28N/A
9/30/201936140-1895N/A
6/30/201933632-19533N/A
3/31/201927723-20737N/A
12/31/201826725-16775N/A
9/30/201826239-17969N/A
6/30/201827051N/A95N/A
3/31/201830358N/A58N/A
12/31/201729765N/A34N/A
9/30/201729875N/A52N/A
6/30/201728265N/A26N/A
3/31/201725757N/A28N/A
12/31/201625058N/A60N/A
9/30/201624852N/A57N/A
6/30/201626861N/A69N/A
3/31/201626963N/A90N/A
12/31/201527563N/A79N/A
12/31/201421339N/A65N/A
12/31/201314217N/A14N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300636's forecast earnings growth (32.9% per year) is above the savings rate (2.8%).

Earnings vs Market: 300636's earnings (32.9% per year) are forecast to grow faster than the CN market (26.3% per year).

High Growth Earnings: 300636's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300636's revenue (23.1% per year) is forecast to grow faster than the CN market (13.9% per year).

High Growth Revenue: 300636's revenue (23.1% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300636's Return on Equity is forecast to be low in 3 years time (7.8%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y